Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2025)
Historic Total Non-Current Liabilities for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $84.9 million.
- Cellebrite DI's Total Non-Current Liabilities rose 4374.97% to $84.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $84.9 million, marking a year-over-year increase of 4374.97%. This contributed to the annual value of $84.9 million for FY2025, which is 4374.97% up from last year.
- Latest data reveals that Cellebrite DI reported Total Non-Current Liabilities of $84.9 million as of Q4 2025, which was up 4374.97% from $69.7 million recorded in Q3 2025.
- Over the past 5 years, Cellebrite DI's Total Non-Current Liabilities peaked at $359.5 million during Q2 2024, and registered a low of $41.4 million during Q3 2021.
- Moreover, its 5-year median value for Total Non-Current Liabilities was $124.8 million (2022), whereas its average is $149.8 million.
- In the last 5 years, Cellebrite DI's Total Non-Current Liabilities skyrocketed by 46644.91% in 2021 and then crashed by 8175.73% in 2025.
- Quarter analysis of 5 years shows Cellebrite DI's Total Non-Current Liabilities stood at $226.6 million in 2021, then crashed by 46.3% to $121.7 million in 2022, then soared by 101.27% to $244.8 million in 2023, then tumbled by 75.89% to $59.0 million in 2024, then skyrocketed by 43.75% to $84.9 million in 2025.
- Its Total Non-Current Liabilities stands at $84.9 million for Q4 2025, versus $69.7 million for Q3 2025 and $69.0 million for Q2 2025.